July 9, 2021 Message from the CEO Earlier this week, the FDA approved the first drug for Alzheimer’s Disease in nearly 20 years. The new drug, Aducanumab, or Aduhelm, is the first Alzheimer’s treatment to attack the disease process instead of just addressing dementia symptoms. The drug is designed to reduce beta amyloid, the protein
May 31, 2021 A monthly recap of the latest news about Alzheimer's & Dementia Earlier diabetes onset could raise dementia risk A new study found that Type 2 diabetes is linked to an increased risk for Alzheimer’s disease and other forms of dementia later in life, and the younger the age at which diabetes is
By Dr. Trinh/ November, 2017 There are three main stages of Alzheimer’s progression: the mild stage, the moderate stage, and the severe stage. Prior to these three stages of the disease is a pre-Alzheimer’s stage, called “Mild Cognitive Impairment” (MCI). During MCI, individuals may occasionally experience memory problems which do not affect their activities of
By Dr. Trinh/ November, 2017 In neuroscience research, a new direction in Alzheimer’s clinical trials is to detect the disease early enough to possibly prevent it from progressing. Now, more and more research companies, including Irvine Clinical Research (ICR), are shifting their focus to trying to find and identify Alzheimer’s while symptoms are still mild
